Lawson Health Research Institute

Canadian Cancer Society to lead nation in cancer prevention and survivorship work with new innovation hub

Retrieved on: 
Wednesday, November 10, 2021
Family, Canadian Cancer Society, Adoption, Center, Cancer, Leukemia, Lower Mainland, Industry, Abbotsford Regional Hospital and Cancer Centre, MLA, Government, Organization, CEO, Survivor, Disease, CCS, Lawson Health Research Institute, COVID-19, Research, CCPS, Canadian Institutes of Health Research, Policy, University Health Network, Partnership, Human, American Cancer Society, Mental health, Awareness, Solution, Strathcona County, EN, Princess Margaret Hospital, Princess, Environment, Climate change, Patient, Life, Public, Leukemia & Lymphoma Society of Canada, Progress, Dietary supplement, Pharmaceutical industry, Birth control, Medical device

Through the Centre, CCS will augment funding for cancer prevention and survivorship research, bring researchers together, and connect them with the people and organizations that can bring research to life.

Key Points: 
  • Through the Centre, CCS will augment funding for cancer prevention and survivorship research, bring researchers together, and connect them with the people and organizations that can bring research to life.
  • This will give Canadians improved access to new cancer prevention and support programs that improve their physical and mental health.
  • As the voice for Canadians who care about cancer, we work with governments to establish health policies to prevent cancer and better support those living with the disease.
  • No other organization does all that we do to improve lives today and to change the future of cancer forever.

Biotech Support Group & Lawson Health Research Institute Enter Collaborative Research Agreement to Monitor Protease Inhibitor Function During Covid-19 Infections

Retrieved on: 
Tuesday, September 28, 2021
Blood, Peptide, ASMS, Goal, Business development, Partnership, Ingo Nugel, Robarts Research Institute, Research, Protein, Mass spectrometry, Patient, Protease, Risk, Partner, LC-MS, Lawson Health Research Institute, Infection, Inflammation, Health, Immunity, Society, Conference, Doctor of Philosophy, Cancer, COVID-19, Poster, Immunoglobulin G, Coagulation, MD, Western University, Biomarker, Business, Method, BSG, Medicine, Proteomics, Growth, Digestion, Disease, Type, Science, Founder, Severe acute respiratory syndrome coronavirus 2, Thrombosis, Lawson, Hospital, Degenerative disease, Enzyme, Intellectual property, Industry, American Society for Mass Spectrometry, Pharmaceutical industry, Vaccine

MONMOUTH JUNCTION, N.J. and LONDON, Ontario, Sept. 28, 2021 /PRNewswire-PRWeb/ -- Biotech Support Group and Lawson Health Research Institute announce a collaborative research agreement.

Key Points: 
  • MONMOUTH JUNCTION, N.J. and LONDON, Ontario, Sept. 28, 2021 /PRNewswire-PRWeb/ -- Biotech Support Group and Lawson Health Research Institute announce a collaborative research agreement.
  • The agreement supports further research to monitor protease inhibitor function acquired from blood collected from hospitalized patients with the SARS-CoV-2 (COVID-19) virus.
  • Lawson Health Research Institute is one of Canada's top hospital-based research institutes, tackling the most pressing challenges in health care.
  • As the research institute of London Health Sciences Centre and St. Joseph's Health Care London, our innovation happens where care is delivered.

Simple medical device improves care after kidney transplantation

Retrieved on: 
Tuesday, June 1, 2021
Anatomy, Medicine, Branches of biology, Kidney transplantation, Organ transplantation, Lawson Health Research Institute, Artificial kidney, Kidney

LONDON, June 1, 2021 /PRNewswire/ -- In a published study , a team from Lawson Health Research Institute (LHSC), in Ontario Canada, has found that a simple medical device can reduce swelling after kidney transplantation.

Key Points: 
  • LONDON, June 1, 2021 /PRNewswire/ -- In a published study , a team from Lawson Health Research Institute (LHSC), in Ontario Canada, has found that a simple medical device can reduce swelling after kidney transplantation.
  • Patients using the device following kidney transplantation experienced shorter hospital stays and reduced surgical site infections by nearly 60 per cent.
  • The geko device has been adopted into the care pathway and is now being offered to patients at LHSC in recovery after receiving a new kidney.
  • "My surgeon explained in very simple terms that it was as if my new kidney wasn't awake yet," describes Garcia.